| Variable Bolus Regimen 1-2-3 for Type 2 Diabetes Mellitus (NCT00135083) | Sanofi | 2004-08-01 |
| AMISH : Aprovel for Management of Isolated Systolic Hypertension (NCT00264212) | Sanofi | 2004-08-01 |
| Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor (NCT00437463) | Sanofi | 2004-07-01 |
| Efficacy and Safety in Patients With Acute Coronary Syndrome Without ST-Segment Elevation (NCT00325390) | Sanofi | 2004-07-01 |
| Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women (NCT00358176) | Sanofi | 2004-07-01 |
| Oxaliplatin in Unresectable Hepatocellular Carcinoma (NCT00280618) | Sanofi | 2004-07-01 |
| Docetaxel + Doxorubicin as Neoadjuvant Chemotherapy in Patients With Breast Cancer (NCT00461344) | Sanofi | 2004-07-01 |
| OPAL - Insulin Glulisine, Diabetes Mellitus (NCT00272012) | Sanofi | 2004-07-01 |
| Study of Live Attenuated Japanese Encephalitis Vaccine (ChimeriVax™-JE) and Yellow Fever Vaccine (STAMARIL®) (NCT00982137) | Sanofi | 2004-07-01 |
| FOCUS:Focus On Coronary Unstable Syndromes (NCT00268619) | Sanofi | 2004-06-01 |
| Risedronate vs Raloxifene in Hormone Replacement Therapy Discontinuation (NCT00790101) | Sanofi | 2004-06-01 |
| Dose-finding, Safety and Efficacy Study of NV1FGF in Patients With Intermittent Claudication (NCT01157871) | Sanofi | 2004-06-01 |
| CASTLE (Clopidogrel And Serum Troponin Level Elevation) (NCT00716924) | Sanofi | 2004-05-01 |
| TEDDY: Spores of Bacillus Clausii in Acute Diarrhoea in Children (NCT00265369) | Sanofi | 2004-05-01 |
| Efficacy and Safety of Rimonabant With or Without Hypocaloric Diet in Obese Patients (NCT00481923) | Sanofi | 2004-05-01 |
| A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis (NCT00632216) | Sanofi | 2004-05-01 |
| LISA-study : Levothyroxin in Nodular Goiter (NCT00277589) | Sanofi | 2004-05-01 |
| Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (NCT00264927) | Sanofi | 2004-05-01 |
| Ketek in CAP / AECB in Ambulatory Adult Patients (NCT00546676) | Sanofi | 2004-05-01 |
| Alfuzosin Versus Placebo in Acute Urinary Retention (NCT00453908) | Sanofi | 2004-05-01 |
| SOLMANIA - Comparison of Valproate-Amisulpride and Valproate-Haloperidol in Bipolar I Patients (NCT00126009) | Sanofi | 2004-05-01 |
| Satavaptan Dose-Ranging Study in Normonatraemic Patients With Cirrhotic Ascites (NCT00501566) | Sanofi | 2004-04-01 |
| Comparison of Efficacy and Safety of Rimonabant 20mg/Day Versus Placebo in Smoking Cessation (NCT00464256) | Sanofi | 2004-04-01 |
| Insulin Glulisine in Healthy Lean and Obese Subjects (NCT00311077) | Sanofi | 2004-04-01 |
| Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia (NCT00313885) | Sanofi | 2004-04-01 |
| Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes (NCT00553020) | Sanofi | 2004-04-01 |
| Leflunomide in Rheumatoid Arthritis (NCT00280644) | Sanofi | 2004-04-01 |
| Satavaptan Dose-Ranging Study in Hyponatraemic Patients With Cirrhotic Ascites (NCT00501722) | Sanofi | 2004-04-01 |
| Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin (NCT00135057) | Sanofi | 2004-04-01 |
| Insulin Glulisine in Type 1 Diabetes Mellitus (NCT00297583) | Sanofi | 2004-04-01 |
| Satavaptan Dose-Ranging Study in the Prevention of Ascites (NCT00501384) | Sanofi | 2004-04-01 |
| Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer (NCT00081796) | Sanofi | 2004-04-01 |
| Rasburicase Versus Allopurinol in Tumor Patients at Risk for Hyperuricemia and Tumor Lysis Syndrome (NCT00230178) | Sanofi | 2004-04-01 |
| Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC) (NCT00174772) | Sanofi | 2004-03-01 |
| Japanese Study Evaluating the Effects of Telithromycin in Children With Community-Acquired Pneumonia (NCT00638859) | Sanofi | 2004-03-01 |
| Long-Term Safety Extension With SR57667B in Patients With Alzheimer's Disease (NCT00285077) | Sanofi | 2004-03-01 |
| RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment (NCT00258921) | Sanofi | 2004-03-01 |
| Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor Malignancy (NCT00230217) | Sanofi | 2004-03-01 |
| Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy (NCT00542165) | Sanofi | 2004-03-01 |
| Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-Small Cell Lung Cancer (NSCLC) (NCT00087802) | Sanofi | 2004-03-01 |
| OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women (NCT00130403) | Sanofi | 2004-03-01 |
| ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis" (NCT00360386) | Sanofi | 2004-03-01 |
| Amisulpride in Schizophrenic Patients (NCT00331981) | Sanofi | 2004-02-01 |
| Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC] (NCT00268710) | Sanofi | 2004-02-01 |
| Japanese Study Evaluating the Effects of Telithromycin in Children With Acute Otitis Media (NCT00638534) | Sanofi | 2004-02-01 |
| VALID : VAlproate Versus LIthium in Bipolar Disorders (NCT00264173) | Sanofi | 2004-02-01 |
| Effects Of Ciclesonide And Beclomethasone On Lens Opacification In Adult Subjects With Moderate To Severe Persistent Asthma (NCT00254956) | Sanofi | 2004-01-01 |
| Dose-Exposure-Response in Type 1 Diabetes Mellitus (NCT00368394) | Sanofi | 2004-01-01 |
| Platelet Aggregation Inhibition in Children on Clopidogrel (PICOLO) (NCT00115375) | Sanofi | 2004-01-01 |
| PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis (NCT00132938) | Sanofi | 2004-01-01 |
| The Incidence of Hypoglycemia in Insulin Glargine-Treated Subjects With Diabetes Mellitus Upon Switching Between Bedtime and Morning Dosing (NCT00609895) | Sanofi | 2004-01-01 |
| Study of the Effect of SR57667B on 18F-Dopa PET Imaging in Patients With Parkinson's Disease (NCT00220272) | Sanofi | 2004-01-01 |
| Risedronate Sodium in Post Menopausal Osteoporosis (NCT00453492) | Sanofi | 2004-01-01 |
| Randomized, Parallel, Comparison, Double-Blind Efficacy & Safety Study of APROVEL Versus Placebo in Chinese Patients With Hypertensive Type II Diabetic Patients With Microalbuminuria (NCT00561964) | Sanofi | 2004-01-01 |
| Safety and Efficacy of Enoxaparin in Percutaneous Coronary Intervention (PCI) Patients, an International Randomized Evaluation (STEEPLE) (NCT00077844) | Sanofi | 2004-01-01 |
| Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients. (NCT00223938) | Sanofi | 2003-12-30 |
| Efficacy and Safety of Insulin Glulisine in Type 2 Diabetes Mellitus (NCT00290927) | Sanofi | 2003-12-01 |
| Irbesartan-Hydrochlorothiazide Phase IV Study: Treatment of Hypertension in Chinese Population (NCT00847834) | Sanofi | 2003-12-01 |
| A Single-Center, Randomized, Double-Blind, Placebo-Controlled, Two-Way Crossover Study Designed to Evaluate the Efficacy of Fexofenadine HCl 180 mg for Preventing and Controlling Cat Allergy Symptoms (NCT00637884) | Sanofi | 2003-11-01 |
| An Efficacy and Safety Evaluation of Nasacort AQ in Children Ages 2-5 Years With Perennial Allergic Rhinitis (NCT00132925) | Sanofi | 2003-11-01 |
| Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine (NCT00825058) | Sanofi | 2003-11-01 |
| An Open-Label 18-Month Safety Study of Fluorouracil Cream 0.5% for the Treatment of Actinic Keratoses (NCT00377273) | Sanofi | 2003-11-01 |
| SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein Thrombosis (NCT00071279) | Sanofi | 2003-11-01 |
| 18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00103649) | Sanofi | 2003-11-01 |
| Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus (NCT00565162) | Sanofi | 2003-11-01 |
| Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type (NCT00104013) | Sanofi | 2003-11-01 |
| Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol (NCT00549133) | Sanofi | 2003-10-01 |
| Ramipril 10 mg/Day Prevention (NCT01053910) | Sanofi | 2003-10-01 |
| Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer (NCT00174863) | Sanofi | 2003-10-01 |
| Satisfaction and Compliance of Risedronate in PMO (NCT00549965) | Sanofi | 2003-10-01 |
| GETNA2 Neoadj. TAX+Femara vs Femara in g I/II Breast Cancer (NCT00617968) | Sanofi | 2003-10-01 |
| Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ (NCT00772928) | Sanofi | 2003-10-01 |
| Assessment of the Immunogenicity and Safety of PENTAXIM™ in Philippines (NCT00254917) | Sanofi | 2003-10-01 |
| Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement (NCT00354939) | Sanofi | 2003-10-01 |
| Weekly Docetaxel and Four Weekly Carboplatin in Non-small Cell Lung Cancer Carbo-Tax (NCT00826852) | Sanofi | 2003-10-01 |
| Oxaliplatin in Gastric Cancer (NCT00263354) | Sanofi | 2003-10-01 |
| Once Daily Given Alfuzosin in the Treatment of BPH (NCT00637715) | Sanofi | 2003-10-01 |
| Single Center, Randomized, Double-Blind,Crossover Study Comparing Effects Of Single-Dose Fexofenadine HCl 180 mg, Cetirizine 10 mg, and Placebo on Cognitive Performance in Naval Flight Personnel (NCT00637455) | Sanofi | 2003-09-01 |
| Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia (NCT00630175) | Sanofi | 2003-09-01 |
| Alfuzosin XL Lower Urinary Tract Symptoms Efficacy and Sexuality Study (NCT00575913) | Sanofi | 2003-09-01 |
| Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine (NCT00825019) | Sanofi | 2003-09-01 |
| DISCO - Influence of a Simple Information Booklet on the Evolution of Acute Low Back Pain (LBP) (NCT00343057) | Sanofi | 2003-09-01 |
| Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer (NCT00772863) | Sanofi | 2003-09-01 |
| Evaluating the Use of SR34006 Compared to Warfarin or Acenocoumarol in Patients With Atrial Fibrillation (AMADEUS) (NCT00070655) | Sanofi | 2003-09-01 |
| PREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin) (NCT00077805) | Sanofi | 2003-08-01 |
| Docetaxel in Squamous Cell Carcinoma of the Head and Neck (TAX + Cisplatin in SCCHN) (NCT00268671) | Sanofi | 2003-08-01 |
| The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) (NCT00069784) | Sanofi | 2003-08-01 |
| Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease (NCT00228150) | Sanofi | 2003-07-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) (NCT00243178) | Sanofi | 2003-07-01 |
| CORE: Capecitabine, Oxaliplatin, Radiotherapy and Excision (NCT00174616) | Sanofi | 2003-07-01 |
| The Efficacy and Safety of Irbesartan 150/12.5 mg and 300/25 mg in Patients With Mild Hypertension (NCT00562809) | Sanofi | 2003-07-01 |
| Fasturtec TLS Treatment / Prophylysis (NCT00651911) | Sanofi | 2003-07-01 |
| FOCUS Fatigue Outcome in Copaxone USers (NCT00267319) | Sanofi | 2003-06-01 |
| SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary Embolism (NCT00062803) | Sanofi | 2003-06-01 |
| Efficacy Study of GEMOX Combination and Vinorelbine in NSCL Patients (NCT00271271) | Sanofi | 2003-06-01 |
| Insulin Glargine Benefits in Japanese Pts Outside of Japan (US or Brazil) (NCT00642915) | Sanofi | 2003-06-01 |
| Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A) (NCT00249873) | Sanofi | 2003-06-01 |
| Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia (NCT00253955) | Sanofi | 2003-06-01 |
| Insulin Glargine in Type 2 Diabetes Mellitus (NCT00311818) | Sanofi | 2003-06-01 |
| Practicability and Acceptability of Stylomax® in Children (NCT00476385) | Sanofi | 2003-06-01 |